Trends in Endometriosis Management: A 10-Year US Claims Analysis

article OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This US claims analysis examined endometriosis management trends over a decade, detailing changes in diagnostic and therapeutic approaches employed by healthcare providers.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

STUDY OBJECTIVE: To examine real-world treatment patterns for endometriosis and their alignment with clinical best-practice recommendations. DESIGN: Observational, retrospective study from 2009 to 2022. SETTING: Two large US health insurance claims databases, MarketScan® and OPTUM®. PATIENTS: Women aged 16-45 years with continuous enrollment in OPTUM® and MarketScan® and at least 2 diagnoses of endometriosis. Hysterectomy, menopause or active treatment of malignancy were exclusion criteria. INTERVENTIONS: Pharmacological therapy (including OCPs, POPs, GnRH analogs, opioids), and surgical management (including laparoscopy and hysterectomy). MEASUREMENTS: Frequencies, means, Time-to-event Kaplan-Meier curves, and Sankey diagrams were used to examine treatment initiation, frequencies and sequences. MAIN RESULTS: A total of 22 317 participants from OPTUM® and 54 630 from MarketScan® were included. Most of these patients (71.0% OPTUM®, 72.1% MarketScan®) received surgery after diagnosis of endometriosis, whereas medications were prescribed in 42.1% (OPTUM®) and 44.9% (MarketScan®). Surgery was performed as a first-line intervention in 37.6% (n = 8395, including 4481 laparoscopies and 3914 hysterectomies in OPTUM®) and 41.8% (n = 22 858, including 13 175 laparoscopies and 9683 hysterectomies in MarketScan®). Among first-line surgeries (n = 8395 OPTUM®, n = 22 858 MarketScan®), laparoscopies accounted for over half (53.4%, n = 4481 OPTUM®; 57.6%, n = 13 175 MarketScan®), while hysterectomies comprised nearly half (46.6%, n = 3914 OPTUM®; 42.4%, n = 9683 MarketScan®). Pharmacotherapy was used first-line in 49.9% (n = 11 135) of OPTUM® and 45.5% (n = 24 840) of MarketScan®. Opioids were used first-line in 12.5% (n = 2787) OPTUM® and 12.7% (n = 6932) MarketScan®. Pharmacological therapies were started as first-line intervention within 15-23 weeks, and surgeries were performed within 16-18 weeks after diagnosis. Those with gynecologic comorbidities had a shorter diagnosis-to-treatment interval than those with mental health and pain comorbidities. CONCLUSION: Therapies for endometriosis are generally started within 4-6 months of diagnosis. Surgery is used more frequently than medical management, and in the majority of cases, surgery was first-line intervention. Opioids are still frequently prescribed despite strong guidelines recommending against their use.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (11)

Cited by (3)

Source provenance

europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-07-28T06:09:46.454568+00:00
unpaywall
last seen: 2026-05-20T11:00:21.680559+00:00
License: CC0 · commercial use OK